Abstract:Background Public resources of chemical compound are in a rapid growth both in quantity and the types of data-representation. To comprehensively understand the relationship between the intrinsic features of chemical compounds and protein targets is an essential task to evaluate potential protein-binding function for virtual drug screening. In previous studies, correlations were proposed between bioactivity profiles and target networks, especially when chemical structures were similar. With the lack of effective quantitative methods to uncover such correlation, it is demanding and necessary for us to integrate the information from multiple data sources to produce an comprehensive assessment of the similarity between small molecules, as well as quantitatively uncover the relationship between compounds and their targets by such integrated schema. Results In this study a multi-view based clustering algorithm was introduced to quantitatively integrate compound similarity from both bioactivity profiles and structural fingerprints. Firstly, a hierarchy clustering was performed with the fused similarity on 37 compounds curated from PubChem. Compared to clustering in a single view, the overall common target number within fused classes has been improved by using the integrated similarity, which indicated that the present multi-view based clustering is more efficient by successfully identifying clusters with its members sharing more number of common targets. Analysis in certain classes reveals that mutual complement of the two views for compound description helps to discover missing similar compound when only single view was applied. Then, a large-scale drug virtual screen was performed on 1267 compounds curated from Connectivity Map (CMap) dataset based on the fused similarity, which obtained a better ranking result compared to that of single-view. These comprehensive tests indicated that by combining different data representations; an improved assessment of target-specific compound similarity can be achieved. Conclusions Our study presented an efficient, extendable and quantitative computational model for integration of different compound representations, and expected to provide new clues to improve the virtual drug screening from various pharmacological properties. Scripts, supplementary materials and data used in this study are publicly available at http://lifecenter.sgst.cn/fusion/ .

Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs

Methods to Profile the Macromolecular Targets of Small Compounds.

Design of Multi-Drug Combinations for Poly-Pharmacological Effects Using Composition-Activity Relationship Modeling and Multi-Objective Optimization Approach: Application in Traditional Chinese Medicine

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Elucidating Compound Mechanism of Action and Polypharmacology with a Large-scale Perturbational Profile Compendium

Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery

Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit

PROMISCUOUS: a database for network-based drug-repositioning

De novo generation of multi-target compounds using deep generative chemistry

Polypharmacological profiling across protein target families and cellular pathways using the multiplexed cell-based assay platform safetyProfiler reveals efficacy, potency and side effects of drugs

Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning

Polypharmacological Drug Design Guided by Integrating Phenotypic and Restricted Fragment Docking Strategies

Use of Natural Products As Chemical Library for Drug Discovery and Network Pharmacology

Exploring polypharmacology of some natural products using similarity search target fishing approach

Predicting compound activity from phenotypic profiles and chemical structures

Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery

Computational Bioactivity Fingerprint Similarities To Navigate the Discovery of Novel Scaffolds

Quantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysis

Multiple target-based pharmacophore design from active site structures

Multiscale Topology in Interactomic Network: From Transcriptome to Antiaddiction Drug Repurposing